Our industry-leading innovation is guided by the experience and influence of our prestigious Medical Advisory Board.
Carlos Buznego, MD, is a Miami-based board-certified ophthalmologist specializing in a range of ophthalmic surgeries including LASIK, laser cataract, and micro-invasive glaucoma surgery. He is an active staff member at Baptist Hospital, Surgical Park Center, and Baptist Medical Arts Surgery Center, as well as a voluntary assistant professor of ophthalmology at the University of Miami’s Bascom Palmer Eye Institute and the Florida International University College of Medicine. Dr. Buznego has been recognized by the American Academy of Ophthalmology for his achievements and has been named one of the “Best Doctors in South Florida” in several polls over the last decade.
Early in his career, he was elected the youngest President in history of the Dade County Medical Association (2001-2002) and the youngest and first Hispanic President of the Florida Society of Ophthalmology. Today, Dr. Buznego is the Chairman of the board of CEDARS/ASPENS. He is also an international lecturer, writes articles about new techniques in his areas of expertise, and is an active clinical researcher and investigator for numerous FDA clinical trials.
Dr. Buznego earned his bachelor’s degree and M.D. at Washington University in St. Louis and completed his training in ophthalmology at the prestigious Bascom Palmer Eye Institute.
Alan Faulkner, MD, is a Hawaii-based board-certified ophthalmologist specializing in refractive cataract procedures. He is the founder and medical director of Aloha Laser Vision (2002) and has been influential in his career to both his colleagues and the next generation of ophthalmologists, having served in numerous academic and leadership positions at his alma mater, Tulane University.
Dr. Faulkner holds numerous professional society memberships including the American Society of Cataract and Refractive Surgeons, the International Society of Refractive Surgeons, and the Hawaii Ophthalmological Society, and he was a founding member of the American College of Ophthalmic Surgery. Dr. Faulkner was named as a Castle Connolly Top Doctor for 2004-2023, a Top Doctor in Hawaii by Honolulu Magazine for 2015-2023, and has also previously been recognized on the Premier Surgeon 300 list for his leadership and innovation in the field of premium refractive cataract surgery. Dr. Faulkner is also on the board of Project Vision Hawai‘i and has several industry affiliations as a speaker, consultant, and clinical researcher.
Dr. Faulkner received his B.A. from Northwestern University and graduated from Tulane Medical School. He remained at Tulane, completing an internship in internal medicine, residency training in ophthalmology, and a fellowship in oculoplastics, ocular oncology, and orbital disease.
Mitchell A Jackson, MD, is a board-certified ophthalmologist specializing in cataract and refractive surgery. He is the founder and CEO of Jacksoneye, his private practice of more than 25 years in Lake Villa, Illinois. Additionally, he is a clinical assistant at the University of Chicago Hospitals. Dr. Jackson has been widely recognized for his achievements, having been selected to the PS250 Premier Surgeon list, OSN300 Refractive Surgeon list, and ASCRS Clinical Subcommittee for Cataract and Refractive Surgery. He also received the 2018 Annual Millennial Award, the 2018 AAO Board of Trustees Achievement Award, and the 2018 Innovation and Founders Award for CEDARS/ASPENS.
Dr. Jackson is a board member of the American College of Eye Surgeons, founding member of the American College of Ophthalmic Surgeons, and founding member and past 2018 President of CEDARS/ASPENS. He also serves on the editorial boards of numerous ophthalmology publications. Dr. Jackson has been involved in many FDA pharmaceutical and surgical clinical studies over the tenure of his practice, including serving as the Global Medical Director of ACE Vision Group.
Dr. Jackson graduated from Pomona College, received his medical degree from the Chicago Medical School, and completed his ophthalmology residency at the University of Chicago Hospitals.
Mark Packer, MD, FACS, CPI, is an internationally recognized leader in ophthalmology and board-certified ophthalmologist. He is an author of original research establishing innovative techniques and groundbreaking technologies and is widely sought for his clinical, medical, and regulatory expertise in ophthalmic drugs and devices. Dr. Packer consults for a multitude of companies and is the Chief Medical Officer for Cassini Technologies and International Biomedical Devices, Inc. He has been awarded for his contributions and leadership in the field, including a Special Recognition Award and an Achievement Award from the American Academy of Ophthalmology.
Dr. Packer has edited textbooks on cataract and refractive lens surgery, written hundreds of book chapters and medical articles, and served as editor for the annual cataract and IOL issue of Current Opinion in Ophthalmology. Elected to membership in the International Intraocular Implant Club (2005), he has delivered hundreds of presentations at scientific meetings around the globe and demonstrated live cataract surgery at conferences worldwide. Additionally, he has served as Principal Investigator or Medical Monitor in over 60 clinical trial protocols that led to FDA clearances and approvals.
Dr. Packer completed his general studies at Harvard University and earned his M.D. from the University of California, Davis, School of Medicine. He completed his residency at Boston University Affiliated Hospitals.
Greg Parkhurst, MD, is the founder and Physician-CEO of Parkhurst NuVision, a rapidly growing ophthalmology group in San Antonio, Texas. Parkhurst NuVision is known internationally as a leading practice in refractive surgery. Listed as one of the Top 40 Under 40 most influential ophthalmologists in the world by The Ophthalmologist, Dr. Parkhurst has helped bring new vision correction procedures to market through research and innovation.
Dr. Parkhurst has been a founding member of multiple ophthalmic professional societies including the American European Congress of Ophthalmic Surgery and the Refractive Surgery Alliance, for which he also served as President for 2 years. He has served as principal investigator for numerous FDA clinical trials, which have led to FDA approvals of some of the most commonly used surgical procedures in ophthalmology today. Dr. Parkhurst has particular expertise with phakic IOLs, having been the highest volume Visian ICL implanted in the U.S. for 2 consecutive years, and has authored multiple papers and textbook chapters on the subject.
Dr. Parkhurst earned his M.D. from Northwestern University. He completed his residency at Walter Reed Army Medical Center and fellowship at the University of Texas and Slade and Baker Vision Center in Houston.
Denise Visco, MD, is an award-winning ocular surgeon and Medical Director. She is the founder of Eyes of York (1996), as well as a freestanding laser vision correction center, also in Pennsylvania. In addition to being certified by the American Board of Ophthalmology, she is among the few elite providers certified by the American Board of Eye Surgery, having performed more than 20,000 no-stitch cataract surgeries and thousands of laser vision correction procedures. In recognition of her leadership and innovation in the field of ophthalmology, Dr. Visco has been named to the prestigious Ocular Surgery News’ Premier Surgeon 300.
Dr. Visco is a pioneer of surgical advancement, as she was the first female surgeon in the world to perform cataract surgery with the LENSAR Laser System. She is also the first in her area to offer all laser LASIK procedures and customized options for cataract surgery, and she opened York County’s first and only ambulatory surgical center specializing in eye surgery. Dr. Visco is a founding member and board member of CEDARS/ASPENS, as well as President of the American College of Eye Surgeons.
Dr. Visco graduated with honors from the University of Delaware, Jefferson Medical College, and Penn State University.
Robert J. Weinstock, MD, is a board-certified ophthalmologist and fellowship-trained cataract and refractive surgeon who has performed over 30,000 cataract and refractive procedures. Dr. Weinstock currently serves as the Director of Cataract and Refractive Surgery at the Eye Institute of West Florida and the Weinstock Laser Eye Center. Dr. Weinstock is also an associate clinical professor at the University of South Florida’s Department of Ophthalmology. He is a world leader and innovator in cataract surgery, having helped develop numerous revolutionary technologies such as microincisional bimanual phaco, intraoperative aberrometry, 3-D surgical guidance, and femtosecond laser cataract surgery.
Additionally, Dr. Weinstock is the Chief Medical Editor for Cataract and Refractive Surgery Today and is on the board of Outpatient Ophthalmic Surgery Society and the CEDARS/ASPENS organization. He also serves on the medical advisory board of many ophthalmic companies. Dr. Weinstock is actively involved in FDA phase III and IV clinical trials, is a well-published author and frequent lecturer, and continues to teach students internationally.
Dr. Weinstock earned his B.A. from Brandeis University and his M.D. from the Chicago Medical School. He completed his residency at the Saint Louis School of Medicine and fellowship at the Eye Institute of West Florida.
Dr. Neda Nikpoor is a fellowship-trained and board-certified ophthalmologist practicing at Aloha Laser Vision in Honolulu, Hawai’i, where she specializes in cataract, corneal, and laser vision surgery. Dr. Nikpoor has made a positive global impact during her career by providing state-of-the-art ophthalmic care to patients worldwide.
After completing her formal training and before going into practice, first in Orange County, California, Dr. Nikpoor spent a year serving the less fortunate through a unique fellowship. She performed hundreds of complex cataract and cornea surgeries and taught extensively in Asia and Africa. During this time, she also worked as a clinical instructor at Stanford University and with the non-profit Himalayan Cataract Project. Her work has led to numerous publications in prominent peer-reviewed publications, such as Ophthalmology, Cornea, and The American Journal of Ophthalmology, and she has also published several textbook chapters. Dr. Nikpoor has been invited to present at numerous regional, national, and international meetings. She is also a member of the ASCRS International Grant Foundation and ASCRS YES Clinical Committees and serves as a CRST Section Editor.
Dr. Nikpoor received her undergraduate and medical degrees from the University of Oklahoma. She attended the renowned Bascom Palmer Eye Institute for her residency in ophthalmology as well as for her fellowship in cornea, external disease, and refractive surgery.
William B. Trattler, MD is a board-certified ophthalmologist practicing at the Center for Excellence in Eye Care in Miami, Florida. Throughout his career, Dr. Trattler has been influential in the field of ophthalmology as a researcher, lecturer, panelist, author, advisor, and board member. He has been recognized at length for his contributions, including the Millennial Award presented by Millennial Eye. He was also named to the Power List: Top 100 Most Influential People in the World of Ophthalmology.
Dr. Trattler has served as an investigator on numerous clinical trials for ophthalmic devices, therapeutics, and innovative cataract technologies, and he is a consultant for various ophthalmic companies. He has served in leadership roles for ophthalmic societies including the American-European Congress of Ophthalmic Surgery (AECOS), the Refractive Surgery Alliance, and the International Society of Refractive Surgery, and he has been deeply involved in the organization of leading scientific meetings. He is widely published, having authored peer-reviewed journal articles, abstracts, presentations, textbooks, textbook chapters, and non-peer reviewed articles.
Dr. Trattler completed his undergraduate degree at Dartmouth College and earned his medical degree with research distinction at the University of Miami School of Medicine. He went on to do his ophthalmology residency at the University of Pennsylvania, followed by his fellowship at the University of Texas Southwestern Medical School.
